TODD WILLIAMS: Open Payments
NPI 1790985463 · ASTORIA, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,231 in 45 payments from 10 companies in 2025. Trend: 2023 $771 · 2024 $1,306 · 2025 $1,231
Food & beverage: $1,028Education: $204
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $319 |
| UCB, Inc. | 11 | $295 |
| Janssen Biotech, Inc. | 4 | $185 |
| Novartis Pharmaceuticals Corporation | 5 | $109 |
| Regeneron Healthcare Solutions, Inc. | 3 | $97 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $95 |
| Lilly USA, LLC | 2 | $48 |
| Organon LLC | 1 | $34 |
| Novo Nordisk Inc | 1 | $29 |
| Galderma Laboratories, L.P. | 1 | $22 |
Products named: Bimzelx, SKYRIZI, TREMFYA, DUPIXENT, COSENTYX, RINVOQ, TALTZ, Ozempic.
Industry payments across OR — which companies pay providers there.
